Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
92.21
+7.21 (8.48%)
Jun 24, 2026, 2:25 PM EDT - Market open
Twist Bioscience Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 409.48 | 376.57 | 312.97 | 245.11 | 203.57 | 132.33 | |
Revenue Growth (YoY) | 17.77% | 20.32% | 27.69% | 20.41% | 53.83% | 46.87% |
Cost of Revenue | 196.25 | 185.57 | 179.63 | 155.38 | 119.33 | 80.62 |
Gross Profit | 213.23 | 191 | 133.35 | 89.73 | 84.24 | 51.71 |
Selling, General & Admin | 272.95 | 246.98 | 218.4 | 189.74 | 212.95 | 135.9 |
Research & Development | 71.89 | 80.29 | 90.85 | 106.89 | 120.31 | 69.07 |
Other Operating Expenses | 7.21 | - | 44.93 | 10.26 | -14.25 | -0.53 |
Total Operating Expenses | 352.05 | 327.26 | 354.18 | 306.89 | 319.01 | 204.44 |
Operating Income | -138.82 | -136.26 | -220.83 | -217.16 | -234.78 | -152.73 |
Interest Income | 9.21 | 11.36 | 15.34 | 14.37 | 3.06 | 0.44 |
Interest Expense | - | - | - | - | -0.08 | -0.37 |
Other Non-Operating Income (Expense) | 49.08 | 47.94 | -2.68 | -0.67 | 3.52 | -1.37 |
Total Non-Operating Income (Expense) | 58.29 | 59.31 | 12.67 | 13.69 | 6.5 | -1.3 |
Pretax Income | -80.53 | -76.95 | -208.17 | -203.47 | -228.27 | -154.03 |
Provision for Income Taxes | 0.74 | 0.72 | 0.56 | 1.15 | -10.41 | -1.93 |
Net Income | -81.28 | -77.67 | -208.73 | -204.62 | -217.86 | -152.1 |
Net Income to Common | -81.28 | -77.67 | -208.73 | -204.62 | -217.86 | -152.1 |
Shares Outstanding (Basic) | 61 | 60 | 58 | 57 | 54 | 48 |
Shares Outstanding (Diluted) | 61 | 60 | 58 | 57 | 54 | 48 |
Shares Change (YoY) | 3.76% | 3.09% | 1.99% | 5.57% | 11.68% | 23.12% |
EPS (Basic) | -1.32 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 |
EPS (Diluted) | -1.33 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 |
Free Cash Flow | -95.04 | -75.63 | -69.17 | -170.25 | -226.24 | -139.31 |
Free Cash Flow Per Share | -1.56 | -1.26 | -1.19 | -2.99 | -4.20 | -2.89 |
Gross Margin | 52.07% | 50.72% | 42.61% | 36.61% | 41.38% | 39.08% |
Operating Margin | -33.90% | -36.18% | -70.56% | -88.60% | -115.33% | -115.41% |
Profit Margin | -19.85% | -20.63% | -66.69% | -83.48% | -107.02% | -114.94% |
FCF Margin | -23.21% | -20.08% | -22.10% | -69.46% | -111.14% | -105.27% |
EBITDA | -114.14 | -111.41 | -189.4 | -187.85 | -218.26 | -142.98 |
EBITDA Margin | -27.87% | -29.58% | -60.52% | -76.64% | -107.22% | -108.04% |
EBIT | -138.82 | -136.26 | -220.83 | -217.16 | -234.78 | -152.73 |
EBIT Margin | -33.90% | -36.18% | -70.56% | -88.60% | -115.33% | -115.41% |
Effective Tax Rate | -0.92% | -0.93% | -0.27% | -0.57% | 4.56% | 1.25% |